Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce the acceptance of two abstracts, for presentation at the AAN 2025 Annual Meeting taking place April 5 – 9, in San Diego. During the event, our expert medical team will highlight our findings, showcasing innovative data and insights […]
Medlive is excited to exhibit at the 2025 AAN Annual Meeting, taking place April 5 – 9, 2025 in San Diego, CA. Visit us at Booth #1622 to see how our solutions are shaping the future of clinician, patient and caregiver education. […]
Historically, patients with HER2-positive metastatic colorectal cancer (mCRC) have had few options for treatment if their condition had progressed following frontline therapy. Recently, novel targeted therapies have entered the treatment landscape for these patients – providing hope for improved patient outcomes. Due to these innovations, an educational need emerged to ensure that these therapies are used effectively in clinical practice. […]
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic condition where growths called polyps form in the nose and sinuses, often due to underlying type 2 inflammation. CRSwNP can cause severe congestion, facial pain and pressure, and loss of smell, impairing quality of life and making daily tasks more difficult. For years, surgery was the main treatment for CRSwNP, and many patients still benefit from it. But polyps return and before the advent of biologics, treatment choices were limited. Today, biologics offer a targeted approach by addressing the underlying inflammation. They can reduce polyp size and improve sense of smell. However, many clinicians and patients remain unfamiliar with these treatments, underscoring the need for education. […]
Leading CME innovation through interactive learning and insights Medlive is excited to exhibit at the Alliance 2025 Annual Conference, January 8–11, 2025, at the Gaylord Palms Resort in Orlando, Florida. Visit us at Booth #500 to learn how Medlive’s advanced solutions and expertise are helping CME professionals elevate healthcare education and improve outcomes. Request a […]
In May of this year, PlatformQ Health launched Medlive, combining the power of our 16 industry-leading therapeutic channels into a singular, dynamic learning platform. Representing much more than a change in name and logo, this transition reinforced our longstanding commitment to bringing innovation and connection to our learners and partners. […]
Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce that two abstracts have been accepted for presentation at the 66th ASH® Annual Meeting and Exposition taking place December 7 – 10, 2024 in San Diego. […]
The treatment of Rett Syndrome (RTT), a rare, genetic neurological disorder affecting young children that leads to severe impairments, is continuing to evolve. The first therapy was approved in March 2023, and with several investigational assets on the horizon, there is a critical need to educate both community-based clinicians and Centers of Excellence on this change to the standard of care. […]
Asthma, a serious chronic lung disease, affects 26.8 million adults and 4.5 million children in the U.S. according to the American Lung Association.1 Research on the pathophysiology of type 2 inflammation has brought new targeted therapies to market that may make a significant difference for patients affected by uncontrolled moderate-to-severe asthma.2 While these innovative biologics play a significant role in treating disease, integration by healthcare practitioners (HCPs) remains inconsistent due to barriers in provider knowledge and confidence. […]
Triple-negative breast cancer (TNBC) remains difficult to treat, and disproportionately affects women of color. To address these challenges, PlatformQ Health joined together with TOUCH: The Black Breast Cancer Alliance and the National Breast Cancer Foundation to develop a tethered educational program to empower patients in treatment decision making and to help facilitate better patient-clinical communication through sharing of real-world outcomes. […]
Early treatment of homozygous familial hypercholesterolemia (HoFH) improves outcomes for children and reduces the risk of progressive atherosclerotic cardiovascular disease. Unfortunately, the disease often goes undetected until it is in the advanced stages. […]
For people with moderate-to-severe asthma, personalization of biologic agents is warranted based on factors such as biomarkers and comorbidities. PlatformQ Health and the Asthma and Allergy Foundation of America (AAFA) conducted a CME-certified, case based, expert panel discussion that featured a live Q&A session with leading faculty from the Asthma Center at Cincinnati Children’s Hospital Medical Center and the Division of Allergy and Immunology at Northwestern University’s Feinberg School of Medicine, as well as AAFA’s public health manager. […]
PlatformQ Health is known for its outcomes-driven education. At this year’s European Conference on Rare Diseases, we co-presented two posters highlighting outcomes and lessons learned from recent programming. […]
The first FDA-approved gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD) is now available. This is a genetic disorder that presents as progressive muscle degeneration and weakness. […]
Decades of research make clear stark disparities in asthma prevalence, mortality, and healthcare utilization along racial and ethnic lines. Black people in the United States, for example, are 1.5 times more likely to have asthma, five times more likely to visit emergency rooms for asthma attacks, and three times more likely to die from the disease. […]
The Asthma and Allergy Foundation of America (AAFA) and PlatformQ Health have extended their long-standing collaboration for another three years to continue bringing trusted digital education to those affected by asthma and related conditions. […]
PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. […]
Clinical trial recruitment has been a persistent problem, with studies showing up to 55% of trials are canceled prematurely due to low enrollment rates. These rates are even more dismal when it comes to diverse populations, including ethnic and racial minorities as well as seniors. Common methods for improving trial access such as transportation supports have been well documented, yet there are numerous other avenues for improving the patient experience that have yet to be uncovered. […]
Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that can influence outcomes. […]
In the wake of FDA approvals for treating myasthenia gravis (gMG, healthcare providers have the ability to individualize treatment. As these new therapies become adopted, it’s crucial to educate patients and providers about issues such as disease presentation, comorbidities, and patient preferences that may impact treatment decisions. […]
The explosion of gene and cell therapies brings promise – and a plethora of questions – from patients and healthcare providers. CAR T-cell therapy is a notable example. These one-time treatments are providing durable remission and in some cases cures of recurrent blood cancers. Due to the complexity of CAR T-cell therapy, it is currently available exclusively at specialized medical centers. […]
PlatformQ Health is excited to share that our poster session “Incorporating the Patient Voice in Rare Disease Education: Multi Stakeholder Collaborations to Improve Diagnosis, Quality of Care, and Outcomes” was selected to be presented both at the 2023 NORD Breakthrough Summit and at the Lighting Round Poster Presentations taking place from 4:30-5:00 PM on Monday, October 16. […]
Numerous posters of educational outcomes have been published at major conferences over the past three years across neuromuscular conditions, including Duchenne muscular dystrophy (DMD), myasthenia gravis (mGM), and spinal muscular atrophy (SMA). These posters highlight the advantages of aligned patient/provider education for closing knowledge gaps and aligning expectations between patients and providers. […]
It’s been a busy season here at the Q, with many educational programs launching across therapeutic areas. Thanks to partnerships with leading advocacy and membership organizations, we have been able to extend access to our trusted education to even more patients, families, and health care providers. Program Highlight We’re particularly excited to share that we’ve […]
There has been much discussion in the medical community about the imperative to improve equity in clinical trials, but what really helps when it comes to changing patient and provider perceptions? […]
Being diagnosed with macular degeneration is a shock to most patients, some of whom have no symptoms at the time. The prospect of losing some, or all of your sight can be devastating, and often leads to depression, as patients worry over the potential loss of independence and changes to their lives. […]
We’re proud to sponsor the 3rd annual Chief Patient Officer Summit, and to participate in an important conversation about improving equitable representation in clinical trials. With five years of producing digital education focused on trial diversity, we’re pleased to be able to share insights into strategies that can change behaviors and break down barriers to trial enrollment. […]
“Black women are 71% more likely to die of breast cancer than their White counterparts, so you have to question what is going on here,” she says. “Although there was knowledge in the medical community about inequities, it seemed like the default response was that this was all associated with poverty or lack of insurance, but what I found is that it’s more nuanced than that. There was bias that was contributing to these disparities. Even if a Black woman had adequate insurance and income, she was often not being presented with the standard of care.” […]
Data collected before and after continuing medical education on the management of familial hypercholesterolemia (HoFH) showed that provider knowledge and competence was notable improved after the session. A poster session presented at the 2023 National Lipid Association Scientific Sessions demonstrated that CME that included patient voice enhanced the ability of providers to adapt to the changing HoFH treatment landscape. […]
There is a high burden of multiple sclerosis (MS) in the Black, Asian, and Hispanic communities, yet clinicians are often not prepared to care for diverse populations of patients. To address this issue, PlatformQ Health and the Consortium of Multiple Sclerosis Centers partnered to develop CME activities, including a 60-minute lecture and 75-minutes of case-based […]
With the growth of biologic agents to treat severe asthma, there is an increased need for shared decision-making between patients and healthcare providers. A poster recently accepted to the 2023 American Thoracic Society conference highlights the value of tethered education (otherwise called aligned education) for this purpose. This involves having a patient program, followed soon after by a provider program where we share insights from the patient program with providers. […]
Racial and ethnic disparities in clinical research leave many patients at a disadvantage, with lack of access to emerging therapies and lack of assurance that newly approved medications will be safe and effective for them. […]
Dementia is one of the biggest global health crises of the 21st century, according to leading neurologists. More than 50 million people are living with the disease, and that number is expected to triple by 2050. Roughly 60-80 percent of dementia cases are Alzheimer’s disease. Specialists are raising awareness that neurodegeneration can begin years, and sometimes decades before a person becomes symptomatic. This is one reason early diagnosis is so crucial. […]
BOSTON AND CHICAGO, APRIL 19, 2023 – and PlatformQ Health have extended their partnership to deliver cutting-edge digital education to the urology community. […]
PlatformQ Health is pleased to announce that noted industry leader Seth Gordon has joined the organization in a senior business development and management role, supporting pharmaceutical clients seeking digital solutions to engage and educate healthcare providers and patients online. […]
Global cases of Alzheimer’s disease (AD) are expected to triple by 2050, according to a recent study presented at the Alzheimer’s Association International Conference. African American and Hispanic American communities are disproportionately affected by the disease, with African Americans having two to three times more instances and Hispanic Americans having 1.5 times more instances of […]
Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Disorders (NORD) to produce digital education for health care providers (HCPs), focused on the rare dermatological condition prurigo nodularis. The 60-minute continuing medication education (CME) […]
The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on the results of recent HCP educational programs focused on Rett syndrome and Alzheimer’s disease. […]
PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array of therapeutic areas. Oncology 2022 Alliance Industry Summit Supplemental Digital Resources CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment Presenting Education Outcomes at […]
Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as antihistamine dosing. […]
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new regimens and practices. […]
As many continuing medication education (CME) program funders will tell you, finding ways to reach medical specialists is often a conundrum. Not only is their time in high demand but they have a plethora of choices when it comes to continuing education. […]
A Look Back on 2022 – Connecting patients, providers, and caregivers through education As we reflect on the past year, we are particularly grateful for the connections we made with our partners, supporters, and colleagues. These connections helped us develop meaningful patient and provider education that impacted 22 million patients. Moving the needle in healthcare […]
Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx of new clinical data and newly approved treatments, there is much education needed to ensure patients and the medical community are aware of these advances. […]
Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. […]
Patients with rare diseases are anxious to find a cure, yet roughly only half ever receive a proper diagnosis. Many of these patients return to their primary care providers (PCPs) frustrated. […]
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. […]
More than half of Americans face financial difficulties paying for medical treatment, according to a recent study. This is particularly relevant in rare diseases and cancer and exacerbates health issues while causing mounting anxiety. […]
With an unprecedented number of drug launches, the need for field force engagement has never been greater – but it’s the right type of engagement that matters. Field reps often perceive that providers want them to identify patient opportunities with new therapies, but a recent study by Bain & Company found that providers actually want their reps to provide trend data, patient support, and introductions to top experts in their field. […]
Early diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) are key to reducing patients’ risk, yet there is low awareness of current guidelines and treatment options among healthcare practitioners. […]
Targeted therapies have allowed for better management of neuroendocrine tumors (NETs), yet this requires that healthcare providers glean new knowledge about treatment options such as somatostatin analogs. To improve provider competency and include consideration of patient perspectives in treatment selection, PlatformQ Health and Healing NET Foundation teamed up with the Moffitt Cancer Center to produce a free educational initiative for providers. […]
PlatformQ Health was invited to present at Bristol Myers Squibb private poster day. The posters present outcomes from two educational initiatives that show positive improvements in patient experience and clinical practice. CME Education Improves Clinical Practice for Treating Ulcerative Colitis Recent changes in understanding the drivers of ulcerative colitis have changed how the disease is […]
In the face of a rapidly shifting landscape of targeted therapies for treating gMG, PlatformQ Health, the National Organization for Rare Disorders (NORD), and the University of North Carolina at Chapel Hill collaborated to develop online CME education about the management of this disease. […]
Patients often face an epic journey of many years before receiving a diagnosis for a rare disease. With nearly one in 10 Americans impacted by a rare condition, it is essential that we decrease the time to diagnosis to improve the lives of these individuals and their families. […]
The management of developmental and epileptic encephalopathies (DEEs) has shifted in recent years, necessitating changes in treatment decisions. In the wake of these changes, PlatformQ Health, the National Organization for Rare Disorders, the Lennox Gastaut Syndrome Foundation, and the University of California, San Francisco came together to produce aligned, online continuing education to support healthcare providers in their ability to diagnose and treat DEEs and help caregivers to engage in care. […]
Ongoing clinician and public education on rare diseases is critical to raising the index of suspicion, decreasing the time to diagnosis, and providing optimal management of patients with these conditions. […]
In our latest partnership newsletter, we highlight some of our recent educational initiatives that address clinical trial equity, tethered education, strategies to improve CME outcomes and more! […]
PlatformQ Health presents a poster at the 2022 ASCO Quality Care Symposium on educational outcomes in Urothelial Carcinoma. […]
Educational outcomes from “Evolving Treatment Approaches for Generalized Myasthenia Gravis to Reduce Disease Burden and Improve Daily Living” accepted at the MGFA Scientific Session at the 2022 AANEM Conference. […]
When a leading biopharmaceutical company began looking for an innovative approach for its speaker programs, they reached out to PlatformQ Health. […]
People of color, the elderly, as well as those living in rural areas are disproportionately affected by cancer, yet are severely underrepresented in cancer clinical trials. The lack of diversity in clinical trials leaves these patients at a severe disadvantage because there is little insight into the safety and effectiveness of therapies for them. […]
When confronting a frightening condition like bladder cancer, patients may fall into a rabbit hole of information online. It can be challenging to discern what sites to trust and where to turn. Not only are patients facing concerns about their own survival, but also worries over sensitive issues such as bladder function and sexual health. In this situation, it can be difficult for patients to open up to providers about their fears. […]
Inclusive clinical trials enable more patients to benefit from therapies that can improve their quality of life. However, an under-representation of racial and ethnic minority groups in clinical trials has been, and continues to be, a major issue within the U.S. healthcare system. “Disparities in clinical research participation are well documented and, like many other […]
Cell and gene therapies are transforming the course of disease treatment, from gene replacement that extends the lives of infants with spinal muscular atrophy, to CAR T-cell therapies that bring durable remission to patients with difficult-to-treat blood cancers. […]
PlatformQ & our strategic partner The Depression and Bipolar Support Alliance are mounting a 2022 MDD summit providing CME accredited education initiatives. The summit will focus on treatment resistance therapies & how to support communities of color & LGBTQ+ youth who experience MDD. […]
Our Summer Partnership Newsletter explores some of the latest and trending medical education topics like the patient voice in CME, tethered education, the future of gene and cell therapy, improving clinical trial access, results from our recent patient survey and more! […]
Primary mitochondrial disease (PMD) is often missed by clinicians due to the broad range of clinical presentations and genetic etiologies. Our recent program “Progressive Myopathy: Could it be a Genetic Mitochondrial Disease?” focused on diagnosing this condition in infants, children, and adults who present with progressive muscle weakness; understanding the diagnostic workup; and manifestations of thymidine kinase 2 (TK2) deficiency. […]
Enhancing CME programs with patient voice is an effective strategy for helping providers retain what they’ve learned. National Organization of Rare Disorders Chief Medical and Science Officer Edward Neilan, MD, PhD noted, “when it comes to educational materials, hearing from the patient makes it much more memorable, much more engaging, and a longer lasting educational contribution.” […]
The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO Annual Meeting that demonstrate the […]
By applying adult learning principles, we’ve discovered that it’s possible to engage providers longer and help them retain more knowledge about a therapy. […]
Researching clinical trials is a formidable challenge. Figuring out which trials offer the most promise to a particular patient is a monumental job, with life-altering implications. With hundreds of thousands of registered clinical trials across the country, it’s no wonder most people are overwhelmed at the prospect of it all. […]
A detailed survey of PlatformQ Health (PQH) digital education attendees found patients and families are realizing meaningful changes as a result of the learnings they gained during these programs. […]
The American Macular Degeneration Foundation (AMDF) and PlatformQ Health have forged an exclusive education partnership. Together, the organizations will deliver cutting-edge, deployable information about macular degeneration to providers, patients, and their families. […]
Carole Drexel, PhD, Medical Director & Vice President of Patient Education will present a poster at the 2022 ASGCT Annual Meeting at 5:30PM in Hall D, demonstrating the ability of digital education to improve healthcare provider (HCP) competency when preparing for a change in care delivery. […]
In collaboration with our partner network, we design education that helps clinicians understand diseases and how to communicate with their patients and empowers patients to become more active participants in their care. […]
We’re pleased to share that the conference has accepted our poster abstract “Impact of Patient-Provider Initiative on Treatment of Pediatric Neuroblastoma” at the 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. […]
May 3, 2022 – The American Society of Gene and Cell Therapy (ASGCT) has formed a strategic alliance with the digital technology and education company PlatformQ Health to deliver in-depth digital education programs for clinicians as well as patients and families. […]
The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. […]
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from diverse racial and ethnic backgrounds. […]
Together with leading advocacy organizations, we’ve created unique learning channels that help make a difference in the lives of patients with conditions such as multiple sclerosis, dementia, and many other neurological conditions. […]
Spring is here and we are excited to share some of our latest articles and webinars that explore pressing medical education and healthcare topics that you may be interested in. Through this seasonal newsletter, we aim to show the breadth and depth of our collaborations and how we work with our partners to go beyond […]
PlatformQ Health is proud to be presenting three posters in Migraine, SMA and Insomnia at the American Academy of Neurology’s Annual 2022 Meeting. […]
“CKD is a silent disease,” said Cheung. “There is significant under-recognition that people may have it. That’s really unfortunate because there are effective therapies, ranging from renin-angiotensin system inhibitors to statins. […]
Promoting new therapies in the rare disease space comes with unique challenges. There are many hurdles to gaining market adoption, particularly for those among the first to market in a disease state. […]
Hear from 10-year cancer survivor, influential advocate and TOUCH CEO, Ricki Fairley, as she dispels myths around clinical trials and discusses how to drive more equitable trial enrollment. […]
In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a patient with MS who has participated in clinical trial research and Sapana Panday, Senior Director of Digital Education at PlatformQ Health. During this conversation the […]
Leaders from the Moffitt Cancer Center, NORD and TOUCH speak on behalf of their organizations about what they are doing in their day to day to make a difference in the lives of Black or other underserved patient populations. […]
A strong pharma product launch can help bolster a drug’s performance over its lifecycle. Most new drugs continue with the revenue trajectory achieved at launch. An analysis by the Deloitte Center for Health Solution found roughly 80 percent of products that met or exceeded initial expectations continued their success rate in subsequent years. That’s why educating physicians quickly in the early months of a product launch delivers a notable advantage. […]
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. As we enter the New Year, our CEO, Robert Rosenbloom took the time to reflect back on 2021 and impact we’ve had on patients, clinicians and caregivers. […]
As our #ASH21 blog comes to a close, the hematology community has much to look forward to with a plethora of clinically relevant data, emerging novel therapies, a better understanding of mechanisms of resistance that can lead to new therapeutic strategies, and a strong commitment from the leading hematology organization to address disparities and ensure equity. […]
Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. […]
Read a short recap of insights about day 2 of ASH, the world’s largest professional society committed to conquering blood diseases, ASH. […]
The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences. […]
Early education of the marketplace is crucial for a successful pharmaceutical product launch. We’re pleased to share how our peer-to-peer education model drives more efficient provider education as well as alignment with the field force. Download the PDF Version: 2021-Infographic-DS Be sure to check out our other End of Year Infographics: Continuing Medical […]
As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We’re pleased to share outcomes from our digital patient education model. Download the PDF version: 2021-Infographic-Patient.pdf Be sure to check out our other End of Year Infographics: […]
Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We’re pleased to share the most significant outcomes across our CME programs and their impact on clinical practice and patient outcomes. Download the PDF version now: […]
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. […]
Tethered education: Aligning patients and providers What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? What barriers to change keep physicians from prescribing new treatments? The practice of shared decision making can help answer these crucial questions. This approach can […]
Clinicians are facing challenges with diagnosing a wide range of conditions. […]
After the CME session, 74 percent of learners reported that the activity positively impacted their clinical practice while 61 percent of learners reported that the activity positively impacted patient experiences and outcomes. […]
Through tethered education PlatformQ Health sought to address educational gaps around understanding treatment options, side effects, side of disability progression, and strategies to manage functional losses. […]
Peer-to-peer engagement can deliver more than mere video views – and can break through digital fatigue.
[…]
PlatformQ Health teamed up with Advances in Neuroblastoma Research Association and Solving Kids’ Cancer to develop two one-hour CME programs for clinicians, patients, and caregivers. […]
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping to reduce time to diagnosis […]
PlatformQ Health regularly tracks the outcomes of its CME courses, and publishes these to share with the medical community. […]
PlatformQ Health is presenting an outcomes poster at the American Society of Retina Specialists 39th Annual Scientific Meeting on the impact of targeted online education. […]
We would like to share some of our latest initiatives, programs, and collaborations, all made possible by our partner network. […]
PlatformQ Health and the American Society for Preventive Cardiology launched a virtual CME program and its outcomes were accepted as a publication of a poster at the Heart Failure Society of America Annual Scientific Meeting 2021. […]
PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of Rare Disorders (NORD) produced a live, 60-minute CME session featuring a neurologist, pulmonologist, genetic counselor, and a patient advocate. […]
In collaboration with our partner, LUGPA, we produced two CME programs that had outcomes accepted at the 2021 ASCO Quality Care Symposium. […]
Discover essential insights for how to drive a compelling digital engagement strategy. […]
New collaborations are bringing innovative approaches to patient outreach and education to address diversity in clinical trials. […]
“Through this collaboration, we are able to reach patients, caregivers, nurses, and physicians to raise awareness about the critical need to increase diversity in cancer clinical trials so that all cancer patients benefit equally from advances in research and have access to potentially life-saving treatments.” […]
Launched today, a new exclusive partnership between Kidney Disease: Improving Global Outcomes (KDIGO) and PlatformQ Health will provide dynamic and engaging content designed to improve health outcomes among individuals living with or at risk for chronic kidney disease. […]
A year-long initiative to produce rare disease digital education made a positive change on clinical practice and patient outcomes. […]
PlatformQ Health is proud to be a platinum sponsor at the 2021 Alliance Connect conference and will be sharing some of the latest insights on measuring health outcomes & accounting for social determinants of health within CPD design. […]
Some of the most important outcomes from the two-part activity highlight clinician barriers to practice in treating HER2/HER3 Metastatic Breast Cancer. […]
Abstract highlighting the impact of a new annual digital conference featuring the latest medical education from top experts on rare blood disorders, leukemias, lymphomas and rare solid tumors accepted at the 2021 ASCO Annual Meeting. […]
Stay up to date with the latest oncology research at the 2021 ASCO Annual Meeting and read more about PlatformQ Health’s educational advances in the ASCO abstract library. […]
The patient voice is the presence of the patients’ lived experiences, values, and preferences in medical education, often in the form of video testimonials. It has the power to spur real change in healthcare by capturing the attention of HCPs and inciting them to make improvements in their practice. […]
PlatformQ Health received the Best in Class award at the Alliance For Continuing Education in the Health Professions 2021 Virtual Alliance Industry Summit for the outcomes poster, “Unearthing the impact of Urology education through in-depth, qualitative interviews.” […]
An e-poster presentation on CIU education for patients, caregivers and health care providers demonstrates the impact of how virtual tethered education can close educational gaps and improve patient experience. […]
Through survey-based evaluation, the poster authors identified educational gaps that will fuel the future learning objectives and topics covered in new and upcoming educational initiatives. […]
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations to address challenges and advances in new treatments. […]
Together, over the years, NORD and PlatformQ Health have closely collaborated to produce a multitude of digital resources for healthcare professionals, patients, and families to facilitate timely diagnosis and improved care. […]
In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. […]
While the COVID-19 pandemic has been socially and economically devastating for us all, the rare-disease community faces a unique set of challenges. Seeking to address these challenges, the National Organization for Rare Disorders (NORD) leveraged Conduit – PlatformQ Health’s proprietary engagement platform – to host the webinar, COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community. […]
PlatformQ Health is launching, “Aligned Health Care Provider and Patient Education on Calcitonin Gene-Related Peptide-Targeted Treatment of Migraine,” a new digital tethered education program, produced in collaboration with the American Migraine Foundation and the National Headache Foundation on January 22, 2021. […]
Our world will be different in 2021 and beyond. The question is, how will we, as a health education community, evolve? Here we are, finally, in 2021. For months we looked forward to turning a new year and imagined life where we are not jumping from crisis to crisis—put simply, life that just feels normal. […]
PlatformQ Health celebrates a busy end to 2020 with 15 digital programs in the month of December, including both accredited online healthcare provider activities and patient education sessions. […]
From patients to caregivers, associations to pharmaceutical companies, COVID-19 ignited transformative digital innovations across healthcare. Robert Rosenbloom, our CEO, reflects on 2020 and looks to the year ahead. […]
Under normal circumstances, managing a complicated health condition can be challenging enough with limited in-person time. Now with COVID-19, doctors are scrambling for new strategies to provide care to their patients, leading to a dramatic increase in the reliance on telemedicine. One solution gaining traction: Tethered education. […]
PlatformQ Health partnered with the American Macular Degeneration Foundation, Opthalmology360, and BroadcastMed to produce a 4-part CME activity. […]
The digital Rare Cancer Congress, held on October 28th and November 12th, engaged community-based clinicians and oncologists in 2 focused tracks on rare hematologic malignancies and rare solid tumors which encompassed 9 interactive, expert-led discussions. […]
PlatformQ Health Education is pleased to announce the publication of three of our outcomes-evaluation abstracts in conjunction with the upcoming 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. […]
PlatformQ Health and the National Organization for Rare Disorders produce 9 rare disease-focused virtual clinician education activities. […]
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. […]
Researcher, Wendy Turell, DrPH, Vice President of CME Outcomes and Analytics at PlatformQ Health Education sought to evaluate and address knowledge and competence gaps when using immunotherapies as treatment for patients with advanced Non-Small Lung Cancer (NSLCL). […]
PlatformQ Health helps long-term rare disease partner, the GBS|CIDP Foundation, transform their 2020 Summit into an interactive, engaging, virtual event. […]
With more than a decade under our belts, PlatformQ Health is the leading provider of interactive online medical education for HCPs, patients, and caregivers. We are proud to be a steady hand for our partners, panelists, supporters, and learners during uncertain times, when the demand for trusted information is so important. We are fortunate to […]
PlatformQ Health has and will continue to collaborate with leading member organizations and patient advocacy group partners to create educational CME series that are live, sequential, interactive, and available for HCPs to watch and re-watch on-demand. […]
NORD leveraged PlatformQ Health’s digital learning platform to give their participants a convenient, user-friendly experience that would allow the rare community to connect and learn effectively, like they would have attending their in-person summit. […]
PlatformQ Health is excited to share an e-poster presentation that was accepted at the 2020 American Academy of Neurology Annual Meeting. […]
PlatformQ Health Education is proud to share that the article “Taking OAB Seriously: A Qualitative Evaluation of Primary Care Education on Overactive Bladder Syndrome Management” is available online, ahead of publication, in the Wiley journal International Journal of Clinical Practice. […]
Online Multi-Year Initiative to produce robust CME series to better equip health care providers in diagnosing, treating and communicating with patients. […]
Rare disease conference to be held online, featuring dedicated tracks patients and families and medical professionals and students. […]
PlatformQ Health is prepared for another jam-packed month of digital programs, including both accredited online healthcare provider activities and patient education sessions. […]
PlatformQ Health, the top provider of virtual healthcare events partners with Susan G Komen®, the world’s leading breast cancer organization to produce an interactive online health care provider and patient education program. […]
PlatformQ Health is thrilled to share two e-poster presentations that will be exhibited at the 80th Scientific Session of the American Diabetes Association (ADA). […]
PlatformQ Health is excited to announce an influx of upcoming June programs including both accredited online healthcare provider activities and patient education sessions produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. […]
Society for Immunotherapy of Cancer (SITC) partners in four-part CME 2020-21 online series on selecting checkpoint inhibitors, overcoming clinical challenges, and enhancing treatment in solid tumors. […]
PlatformQ Health Education is excited to present Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments, a free online CME session produced in partnership with the American Society for Preventive Cariology and accredited by the Joslin Diabetes Center (JOS). […]
PlatformQ Health is excited to share a scientific poster that showcases the results from the patient and caregiver online educational program, Positive Knowledge and Behavior Shift Following Video-Based Patient Education on Pancreatic Cancer. […]
PlatformQ Health is excited to share a poster that showcases the results from the continuing medical education (CME) program, CGRP Blockage: The Evolving Landscape of Migraine Therapy, that was accepted at the 2020 American Academy of Neurology (AAN) Annual Meeting. […]
PlatformQ Health is excited to share results from an HCP and patient education initiative that were to be presented as two uniquely focused poster presentations at the American Academy of Allergy, Asthma and Immunology’s Annual Meeting and the American Academy of Dermatology’s 2020 Annual Meeting, respectively. […]
We surveyed more than 200 HCPs to learn more about how they plan on learning in our ‘new normal’ and what information they’re seeking most often now. […]
PlatformQ Health is excited to share a poster presentation that was accepted at the Oncology Nursing Society’s 45th Annual Congress, that shares insights from three online CME programs addressing nursing care for pediatric patients with high-risk neuroblastoma. […]
PlatformQ Health is pleased to announce two new programs dedicated to updating health care professionals about telehealth and practice management, both produced in partnership with LUGPA. […]
The PlatformQ Health Team would like to extend our heartfelt gratitude today, on National Doctor’s Day, to the physicians who tirelessly dedicate themselves to the health and safety of their patients. […]
PlatformQ Health’s oncology team recognizes your need for information on practice changes to allow you, clinicians on the front line, to continue treating and protecting vulnerable patient populations. […]